Alcon Seed Fund
Through strategic investments and collaborations, the Alcon Seed Fund accelerates the advancement of breakthrough solutions that address unmet clinical needs and improve patient outcomes globally.
What Companies can Expect from Entering the Alcon Seed Fund Process
Submitted proposals are triaged based on their alignment with Alcon Seed Fund focus areas
Selected companies present their technology on a non-confidential basis for Alcon to determine strategic fit and gauge interest in collaboration
Companies discuss key diligence questions, development milestones and planned use of proceeds with Alcon R&D experts
Companies present to R&D Executive Leadership at the ASF Investment Committee meeting, where investment decisions are made
Overview of the Alcon Seed Fund Process
We are dedicated to helping people see brilliantly by offering the widest array of eye care and eye health offerings with products that can treat the entire eye at each stage of life.
STRATEGIC SELECTION
We seek potentially disruptive technologies aligned with Alcon's focus areas and strategic priorities
EXPERT EVALUATION
We thoroughly evaluate selected proposals for their ability to meet our investment criteria
INVESTMENT
We fund technologies that have the potential to significantly advance ocular diseases management and complement Alcon pipeline
LIFECYCLE
Upon successful achievement of development milestones, and at Alcon's sole discretion, recipients may receive further funding
Key Focus Areas
Cataract
Advanced instrumentation, new IOL materials or designs with opportunity for enhanced performance
Myopia
Device-based modalities with enhanced effectiveness vs. available treatment options
Retina
Technologies or systems that can be used to visualize, diagnose or treat retinal diseases
Ocular Health
Interventions that improve health status of the ocular surface
Glaucoma
Medical Devices with step change improvement in risk-benefit for office-based or surgical interventions
Contact Lenses
New optic and device technologies to drive incremental or breakthrough product performance in key indications, including myopia and presbyopia
Digital Technologies
Improved visualization, analysis or modeling tools to support diagnosis, treatment planning and guided surgery; clinical decision support system
White Space
Novel technologies with the potential to revolutionize the treatment of ophthalmic diseases
Alcon Seed Fund Opportunities Inquiry
We routinely screen for emerging technology opportunities that could enhance existing product offerings or lead to innovative new products in the field of ophthalmology.
Complete the form below with only NON-CONFIDENTIAL information for a new product innovation or technology.
Alcon will be under no obligation to treat any information provided in this manner as confidential regardless of any legend or statement contained therein or set forth with respect thereto. Please only submit non-confidential information after you have first taken steps to obtain patent protection.
With each submission, you agree to seek and rely exclusively upon your patent rights, if any, as defined by the claims of an issued patent and that you will not submit suggestions for ideas that are subject to protection by design patents, copyrights, or trademarks. Further, you understand that Alcon may currently be developing, or have plans to develop, products or processes similar to what you have submitted.